避妊薬の市場規模・シェア・成長分析 (種類別、流通経路別、地域別)：産業予測 (2024～2031年)

世界の避妊薬の市場規模は、2022年に195億米ドルと評価され、2023年の210億8,000万米ドルから2031年には393億1,000万米ドルに成長し、予測期間中 (2024年～2031年) のCAGRは8.1%で成長する見通しです。

避妊薬とデバイスの市場は、性感染症の罹患率の上昇と、こうした選択肢を利用できない女性の増加により、成長が見込まれています。世界保健機関 (WHO) が強調しているように、2019年には11億人以上の生殖年齢の女性が家族計画を必要としており、2億7,000万人が満たされない需要を経験しています。ターゲットを絞ったプログラムや意識の向上を通じて計画外妊娠に対処する取り組みは、市場拡大の原動力になると予想されます。逆に、避妊薬に伴う副作用、不妊率の増加に対する懸念、先進国における性教育の不統一といった課題は、成長を阻害する可能性があります。こうした力学は、避妊薬市場におけるアクセシビリティとユーザー満足度を高めるための革新的ソリューションの必要性を強調しています。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場魅力度指数 (2023年)
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

世界の避妊薬の市場規模・CAGR：種類別 (2024～2031年)

• 市場概要
• 経口避妊薬
• 複合経口避妊薬
• プロゲストーゲン専用錠剤
• 局所避妊薬
• 避妊注射剤
• その他

世界の避妊薬の市場規模・CAGR：流通経路別 (2024～2031年)

• 市場概要
• 病院・クリニック
• 小売薬局
• オンライン薬局
• その他

世界の避妊薬の市場規模・CAGR (2024～2031年)

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要企業が採用した戦略
• 市場の近年の動向
• 主要企業の市場シェア（2023年）
• 主要企業のプロファイル
  • 企業概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較 (2021～2023年)

主要企業プロファイル

• Pfizer Inc. (米国)
• Bayer AG (ドイツ)
• Teva Pharmaceutical Industries Ltd. (イスラエル)
• Mylan N.V. (オランダ)
• Novartis AG (スイス)
• Johnson & Johnson (米国)
• GlaxoSmithKline plc (UK)
• Allergan plc (アイルランド)
• Agile Therapeutics, Inc. (米国)
• Piramal Healthcare (インド)
• Organon & Co. (オランダ)
• HRA Pharma (フランス)
• CooperSurgical, Inc. (米国)
• Church & Dwight Co., Inc. (米国)
• Merck & Co., Inc. (米国)
• Famy Care Ltd. (インド)
• Sinopharm Group Co., Ltd. (中国)
• Sun Pharmaceutical Industries Ltd. (インド)
• Torrent Pharmaceuticals Ltd. (インド)
• Dr. Reddy's Laboratories Ltd. (インド)

結論と推奨事項

Global Contraceptive Drugs Market size was valued at USD 19.5 billion in 2022 and is poised to grow from USD 21.08 billion in 2023 to USD 39.31 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).

The market for contraceptive drugs and devices is poised for growth due to the rising incidence of sexually transmitted diseases and an increasing number of women lacking access to these options. As highlighted by the World Health Organization, in 2019, more than 1.1 billion women of reproductive age were in need of family planning, with 270 million experiencing unfulfilled demand. Efforts to address unplanned pregnancies through targeted programs and heightened awareness are expected to drive market expansion. Conversely, challenges such as side effects associated with contraceptives, concerns over growing infertility rates, and inconsistencies in sex education in developed nations may impede growth. These dynamics underscore the need for innovative solutions to enhance accessibility and user satisfaction in the contraceptive market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contraceptive Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contraceptive Drugs Market Segmental Analysis

Global Contraceptive Drugs Market is segmented by type, distribution and region. Based on type, the market is segmented into oral contraceptives, combined oral contraceptive pills, progestogen-only pills, topical contraceptives, contraceptive injectable and others. Based on distribution, the market is segmented into hospital & clinics, retail pharmacy, online pharmacy and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Contraceptive Drugs Market

The Global Contraceptive Drugs market is significantly driven by the need to prevent unwanted pregnancies, particularly among poor and low-income populations where the incidence of unintended pregnancy remains high. A key factor behind this issue is the reliance on traditional contraception methods, which are often less effective. This situation is further compounded by the prevalence of unsafe abortions and associated maternal mortality rates. For instance, in Latin America, adolescents under 16 face a fourfold increase in the risk of maternal death compared to women in their thirties. Consequently, the adoption of contraceptive drugs plays a vital role in reducing the rates of unplanned pregnancies, thereby improving maternal health outcomes.

Restraints in the Global Contraceptive Drugs Market

The global contraceptive drugs market is facing significant constraints due to the adverse effects associated with birth control pills. Prolonged use, defined as ten years or more, can lead to various side effects including headaches, nausea, and abnormal bleeding. Additionally, medications that contain estrogen and progesterone have been linked to an elevated risk of developing blood clots, which can result in serious complications such as heart attacks. These potential health risks contribute to consumer hesitancy and reduce market demand, ultimately impeding the growth of the contraceptive drugs sector worldwide. Addressing these concerns is crucial for market expansion.

Market Trends of the Global Contraceptive Drugs Market

The Global Contraceptive Drugs market is experiencing a significant shift towards innovative technological advancements, particularly in the realm of digital contraception. This trend encompasses a growing emphasis on period tracking applications that empower users to monitor their menstrual cycles and assess pregnancy risk. A notable example is Berlin-based Clu's all-digital contraceptive, Clu Birth Control, which leverages comprehensive period data and predictive algorithms to enhance contraceptive efficiency. The ability for users to adjust their sexual behaviors based on personalized risk analytics positions digital contraception as a game-changer in reproductive health, reflecting a broader consumer demand for tailored, tech-driven contraceptive solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Contraceptive Drugs Market Size by Type & CAGR (2024-2031)

• Market Overview
• Oral Contraceptives
• Combined Oral Contraceptive Pills
• Progestogen-Only Pills
• Topical Contraceptives
• Contraceptive Injectable
• Others

Global Contraceptive Drugs Market Size by Distribution & CAGR (2024-2031)

• Market Overview
• Hospital & Clinics
• Retail Pharmacy
• Online Pharmacy
• Others

Global Contraceptive Drugs Market Size & CAGR (2024-2031)

• North America (Type, Distribution)
  • USA
  • Canada
• Europe (Type, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HRA Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Famy Care Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinopharm Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations